Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal

B Pongiglione, A Torbica, H Blommestein… - International journal of …, 2021 - cambridge.org
AimTechnological and computational advancements offer new tools for the collection and
analysis of real-world data (RWD). Considering the substantial effort and resources devoted …

[HTML][HTML] Quo vadis HTA for medical devices in Central and Eastern Europe? Recommendations to address methodological challenges

R Daubner-Bendes, S Kovács, M Niewada… - Frontiers in public …, 2021 - frontiersin.org
Objectives: Methodological challenges in the evaluation of medical devices (MDs) may be
different for early and late technology adopter countries, as well as the potential health …

Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders

KM Facey, P Rannanheimo, L Batchelor… - International journal of …, 2020 - cambridge.org
ObjectivesThere are divergent views on the potential of real-world data (RWD) to inform
decisions made by regulators, health technology assessment (HTA) bodies, payers …

How to deal with the inevitable: generating real-world data and using real-world evidence for HTA purposes–from theory to action

W Oortwijn, L Sampietro-Colom… - International journal of …, 2019 - cambridge.org
ObjectivesReal-world evidence (RWE), derived from real-world data (RWD), is already used,
to some extent, for health technology assessment (HTA) purposes. With the increased …

[HTML][HTML] Critical review of European health-economic guidelines for the health technology assessment of medical devices

M Blüher, SJ Saunders, V Mittard… - Frontiers in …, 2019 - frontiersin.org
Background: Health-technology assessment (HTA) is a recognized mechanism to determine
the relative benefits of innovative medical technologies. One aspect is their health-economic …

Using real-world evidence in healthcare from Western to Central and Eastern Europe: a review of existing barriers

M Kamusheva, B Nemeth… - Journal of …, 2022 - becarispublishing.com
As part of the HTx (Next Generation Health Technology Assessment) project, this study was
aimed at identifying the main barriers for application of real-world evidence (RWE) for the …

Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward

J Lou, KC Sarin, KY Toh, S Dabak, A Adler… - International journal of …, 2020 - cambridge.org
There is growing interest globally in using real-world data (RWD) and real-world evidence
(RWE) for health technology assessment (HTA). Optimal collection, analysis, and use of …

[HTML][HTML] Real world data in health technology assessment of complex health technologies

MA Hogervorst, J Pontén, RA Vreman… - Frontiers in …, 2022 - frontiersin.org
The available evidence on relative effectiveness and risks of new health technologies is
often limited at the time of health technology assessment (HTA). Additionally, a wide variety …

[HTML][HTML] Structure and content of a taxonomy to support the use of real-world evidence by health technology assessment practitioners and healthcare decision makers

LA Murphy, R Akehurst, O Solà-Morales… - Value in Health, 2023 - Elsevier
This is one of a series of articles that consider the barriers to optimal use of real-world
evidence (RWE) in health technology assessment and how to overcome them. The work …

[HTML][HTML] Transferability of real-world data across borders for regulatory and health technology assessment decision-making

A Jaksa, PJ Arena, KKW Chan, RH Ben-Joseph… - Frontiers in …, 2022 - frontiersin.org
Recently, there has been increased consideration of real-world data (RWD) and real-world
evidence (RWE) in regulatory and health technology assessment (HTA) decision-making …